These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 15356788)

  • 21. The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women.
    Maurer T; Rodrigues LK; Ameli N; Phanuphak N; Gange SJ; DeHovitz J; French AL; Glesby M; Jordan C; Khalsa A; Hessol NA
    Clin Infect Dis; 2004 Feb; 38(4):579-84. PubMed ID: 14765353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of highly active antiretroviral therapy among HIV-1 infected women.
    Gange SJ; Barrón Y; Greenblatt RM; Anastos K; Minkoff H; Young M; Kovacs A; Cohen M; Meyer WA; Muñoz A;
    J Epidemiol Community Health; 2002 Feb; 56(2):153-9. PubMed ID: 11812817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
    Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
    J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of HIV Infection and Highly Active Antiretroviral Therapy on Hearing Function: A Prospective Case-Control Study From Cameroon.
    Fokouo JV; Vokwely JE; Noubiap JJ; Nouthe BE; Zafack J; Minka Ngom ES; Dalil AB; Ngo Nyeki AR; Bengono G; Njock R
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):436-41. PubMed ID: 25741887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initiation of regular marijuana use among a cohort of women infected with or at risk for HIV in the Women's Interagency HIV Study (WIHS).
    Kuo WH; Wilson TE; Weber KM; Madhava V; Richardson J; Delapenha R; Des Jarlais D
    AIDS Patient Care STDS; 2004 Dec; 18(12):702-13. PubMed ID: 15659881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women.
    Cook JA; Cohen MH; Burke J; Grey D; Anastos K; Kirstein L; Palacio H; Richardson J; Wilson T; Young M
    J Acquir Immune Defic Syndr; 2002 Aug; 30(4):401-9. PubMed ID: 12138346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations.
    Ameli N; Bacchetti P; Morrow RA; Hessol NA; Wilkin T; Young M; Cohen M; Minkoff H; Gange SJ; Greenblatt RM
    AIDS; 2006 Apr; 20(7):1051-8. PubMed ID: 16603858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women.
    Merenstein D; Wang C; Gandhi M; Robison E; Levine AM; Schwartz RM; Weber KM; Liu C
    Complement Ther Med; 2012 Aug; 20(4):222-7. PubMed ID: 22579434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women.
    Vaamonde CM; Hoover DR; Anastos K; Tan T; Shi Q; Gao W; Kovacs A; Cohen M; DeHovitz J; Glesby MJ
    AIDS Res Hum Retroviruses; 2006 Mar; 22(3):222-31. PubMed ID: 16545008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review.
    Crepaz N; Hart TA; Marks G
    JAMA; 2004 Jul; 292(2):224-36. PubMed ID: 15249572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship of pregnancy to the use of highly active antiretroviral therapy.
    Minkoff H; Ahdieh L; Watts H; Greenblatt RM; Schmidt J; Schneider M; Stek A
    Am J Obstet Gynecol; 2001 May; 184(6):1221-7. PubMed ID: 11349192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orofacial lesions associated with long-term highly active antiretroviral therapy among HIV-seropositive adults in Ibadan, Nigeria.
    Abe OE; Fagbule OF; Olaniyi OO; Adisa AO; Gbolahan OO
    Pan Afr Med J; 2021; 38():370. PubMed ID: 34367449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients.
    Bergersen BM; Sandvik L; Dunlop O; Birkeland K; Bruun JN
    Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):731-6. PubMed ID: 14610658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS).
    Solomon L; Stein M; Flynn C; Schuman P; Schoenbaum E; Moore J; Holmberg S; Graham NM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):253-61. PubMed ID: 9495226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
    Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States.
    Dale S; Cohen M; Weber K; Cruise R; Kelso G; Brody L
    AIDS Patient Care STDS; 2014 Mar; 28(3):136-43. PubMed ID: 24568654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.